Difference between revisions of "Ziprasidone"
From Psychiatrienet
| Line 8: | Line 8: | ||
| emea = | | emea = | ||
| ftk = - | | ftk = - | ||
| − | | metabolization = Ziprasidone is metabolized by CYP1A2 (minor) and CYP3A4. | + | | metabolization = * Ziprasidone is metabolized by CYP1A2 (minor) and CYP3A4. |
| metabolization_ref =<ref>Bazire S; Psychotropic drug directory, 2007</ref> | | metabolization_ref =<ref>Bazire S; Psychotropic drug directory, 2007</ref> | ||
| <includeonly> isswitch=1</includeonly> | | <includeonly> isswitch=1</includeonly> | ||
}} | }} | ||
Revision as of 18:13, 8 June 2010
| Ziprasidone | |||
| Type | Antipsychotic | ||
| Group | Atypical AP | ||
| Other use | Moodstabilizer | ||
| links | |||
| Medscape | Ziprasidone | ||
| PubChem | 60854 | ||
| PubMed | Ziprasidone | ||
| Wikipedia | Ziprasidone | ||
| |||
Ziprasidone is a Antipsychotic in the group Atypical AP. Ziprasidone is also used as Moodstabilizer.
- Metabolization
- Ziprasidone is metabolized by CYP1A2 (minor) and CYP3A4.[1]
- ↑ Bazire S; Psychotropic drug directory, 2007
